AcquisitionOther
Orchestra BioMed Holdings, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Orchestra BioMed Holdings, Inc. -> target · $70 million
Gross proceeds from the business combination were $70 million including $20 million in market purchases of HSAC2 stock by an affiliate of Medtronic plc ("Medtronic") and funds managed by RTW Investments, LP ("RTW"), a leading life sciences investment firm, as
Open source record (SEC) ↗